TCR2 Therapeutics Insider Trades Send a Signal
| TCRRDelisted Stock | USD 1.48 0.00 0.00% |
Slightly above 56% of Tcr2 Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Tcr2 Therapeutics suggests that many traders are alarmed regarding Tcr2 Therapeutics' prospects. Tcr2 Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Tcr2 Therapeutics. Many technical investors use Tcr2 Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tcr2 |
Read at benzinga.com
 |
Tcr2 Therapeutics Fundamental Analysis
We analyze Tcr2 Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tcr2 Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tcr2 Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Tcr2 Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Tcr2 Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tcr2 Therapeutics stock to make a market-neutral strategy. Peer analysis of Tcr2 Therapeutics could also be used in its relative valuation, which is a method of valuing Tcr2 Therapeutics by comparing valuation metrics with similar companies.
Peers
Tcr2 Therapeutics Related Equities
| PASG | Passage Bio | 45.61 | ||||
| AFMD | Affimed NV | 13.45 | ||||
| ALEC | Alector | 8.99 | ||||
| AGEN | Agenus | 5.83 | ||||
| BDTX | Black Diamond | 2.80 | ||||
| STOK | Stoke Therapeutics | 1.95 | ||||
| ADCT | ADC Therapeutics | 1.00 | ||||
| RVMD | Revolution Medicines | 0.27 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Tcr2 Stock
If you are still planning to invest in Tcr2 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tcr2 Therapeutics' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |